First order from France

Pharmacolog’s distributor has ordered a first system to be placed at Hôspital du Confluent in Nantes. The system shall be used for the final control of chemotherapy drugs toxicity at the hospital pharmacy. Pharmed won the order in competition with other suppliers.

During 2016, Pharmed has deliberately processed the French market, focusing on hospital pharmacies that prepare for chemotherapy and has now placed the first order on a DrugLog system. The system will be placed at the Hôspital du Confluent in Nantes and will be used for the final control of chemotherapy drugs prepared made at the hospital pharmacy. The deal means that, according to agreement, Pharmed purchases a DrugLog® systems from Pharmacolog for delivery to the hospital and results in a certain turnover impact.

CEO Mats Högberg comments: “It is extremely pleasing that Pharmed managed to get his first order. Key benefits that played an important role for the decision was DrugLog’s speed and ease of use. Then, of course, it’s extra satisfying to win a deal where we competed against a domestic French competitor. The deal is a result of the purposeful and long-term work of our Pharmed distributor, which is now beginning to show results. ”

Didier Dubois, Sales Manager at Pharmed SAM: “We have been working methodically in introducing the DrugLog concept in France and are very happy to be able to close our first deal. The interest for DrugLog is increasing and our sales funnel steadily growing. There is definitely a strong demand for efficient solutions for validation of chemo drugs in the French market so we have great hope that Nantes will be followed by many others.”

New analysis of Pharmacolog

New company analysis of Pharmacolog AB performed by Jarl Securities. Read the complete analysis here (in Swedish only):

Pharmacolog signs a collaboration agreement with researchers at Uppsala University regarding antibiotic treatment

Pharmacolog AB has entered a research and development cooperation with researchers from Uppsala University regarding methods for determining antibiotic concentration in the blood during treatment of patients with severe infections.

Antibiotic treatment with the right dose is crucial for patients to survive severe infections. Today, technology is lacking to quickly determine blood concentrations of antibiotics in patients treated for serious infections. The collaboration between Pharmacolog AB and Professor Miklos Lipcsey at the Department of Surgical Sciences and Professor Anders Larsson at the Department of Medical Sciences, both at Uppsala University, is a result of preparatory tests of the abi...

Pharmacolog Appoints New Sales and Marketing Manager

Pharmacolog appoints Kent Öbrink as new Sales and Marketing Manager. Kent has more than 20 years of experience in qualified healthcare sales and a solid international experience. Kent will start on 1 of June and comes from C-Rad AB, where he held the role of Global Sales Manager.

As sales and marketing manager, Kent Öbrink will be responsible for the company’s commercial activities and for collecting important market intelligence before new development projects. Kent is a qualified microbiologist, but soon entered sales and marketing with a job as a Sales Representative at Kabi Pharmacia in 1991. After that, Kent held several qualified sales manager positions within the company until 1999, ...

Pharmacolog Appoints New Development Manager

Pharmacolog appoints Jörgen Höjdmo as the new Development Manager. Jörgen has extensive experience in leading advanced development projects and is one of the main architects of the company’s current DrugLog® systems.

As a development manager Jörgen will be responsible for the company’s product development and manage internal and external resources. Jörgen Höjdmo has a MSc in Engineering Physics and more than 20 years of experience in technology and software development. He has also worked as CEO of Digital Diary AB, which later was sold to FormPipe AB 2005 where Jorgen continued to work as a Partner Manager until 2007. The last 10 years has Jörgen mainly worked as a consultant in mana...